510(k) · Cleared
ClearedKirschner Knee Modified
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet, Inc. · JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Cleared on Mar 17, 1997 as substantially equivalent to K915132 (Biomet, Inc., 1992) and 1 other predicate after a 368-day review. Its family tree reaches back 1 generation to 1984. 7 later devices descend from it.
- Decided
- Mar 17, 1997
- Review
- 368 days
- Class
- Class II
- Product code
- JWH
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K833921 (1984). 2 ancestors in all. 7 later devices descend from it, 1 citing it directly.
- Root · 1 generation backK833921 Agc Total Knee ProsthesisBiomet, Inc. · 1984 · Recalled
- This deviceK961021 Kirschner Knee ModifiedBiomet, Inc. · 1997
- Descendant · cites it directly · 6 of its ownK122160 Vanguard XP Knee SystemBiomet Manufacturing Corp · 2013 · Recalled
- Descendant · 2 generations on · 3 of its ownK132873 Vanguard XP Knee SystemBiomet, Inc. · 2013 · Recalled
- Descendant · 2 generations on · 2 of its ownK141407 Vanguard XP Femoral Component (Gen II)/Vanguard XP Femoral TrialBiomet, Inc. · 2014 · Recalled
- Descendant · 2 generations on · 1 of its ownK153657 Vanguard XP Knee SystemBiomet, Inc. · 2016 · Recalled
- Descendant · 2 generations on · 0 of its ownK190068 Vanguard XP Knee SystemZimmer, Inc. · 2019
Showing 5 of 7 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 7 · See all- K122160Vanguard XP Knee SystemBiomet Manufacturing Corp · 2013 · cites it directly6descendants
- K132873Vanguard XP Knee SystemBiomet, Inc. · 2013 · 2 generations on3descendants
- K141407Vanguard XP Femoral Component (Gen II)/Vanguard XP Femoral TrialBiomet, Inc. · 2014 · 2 generations on2descendants
- K153657Vanguard XP Knee SystemBiomet, Inc. · 2016 · 2 generations on1descendant
- K190068Vanguard XP Knee SystemZimmer, Inc. · 2019 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K833921 | Agc Total Knee Prosthesis | Biomet, Inc. | 1984 | 2 |
| 0 (this device) | K961021 | Kirschner Knee Modified | Biomet, Inc. | 1997 | — |
| +1 | K122160 | Vanguard XP Knee System | Biomet Manufacturing Corp | 2013 | 12 |
| +2 | K132873 | Vanguard XP Knee System | Biomet, Inc. | 2013 | 22 |
| +2 | K141407 | Vanguard XP Femoral Component (Gen II)/Vanguard XP Femoral Trial | Biomet, Inc. | 2014 | 1 |
| +2 | K153657 | Vanguard XP Knee System | Biomet, Inc. | 2016 | 1 |
| +2 | K190068 | Vanguard XP Knee System | Zimmer, Inc. | 2019 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1992 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 2 | 0 |
| 2014 | 2 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2019 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JWH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JWH device
- #1 K221479 Persona Personalized Knee Systemscore 22.4 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K915132 | MCK Maximum Congruent Knee) Knee SystemSummary page 2…, Biomet's Kirschner Knee Modified knee components are equivalent to aimost any knee components on the market, including: Maxim Total Knee System (Biomet, Inc.) 510(k)# K915132 cleared for market 2/11/92. AGC 2000 Total Knee Prosthesis (Biomet, Inc.) 510(k)# K833921 cleared for market 1/31/84. | 1992 |
| * | K833921 | Agc Total Knee ProsthesisSummary page 2…ents on the market, including: Maxim Total Knee System (Biomet, Inc.) 510(k)# K915132 cleared for market 2/11/92. AGC 2000 Total Knee Prosthesis (Biomet, Inc.) 510(k)# K833921 cleared for market 1/31/84. | 1984 |
What descends from it? (7)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K122160 | Vanguard XP Knee System | 2013 | 6 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All JWH devicesJWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JWH
20in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · JWH
55in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JWH
2in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JWH
9,306in 2025
MAUDE reports naming product code JWH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 18 | 74 | 14 | 1,305 |
| 2008 | 17 | 81 | 10 | 1,483 |
| 2009 | 11 | 168 | 109 | 1,870 |
| 2010 | 19 | 85 | 32 | 3,286 |
| 2011 | 25 | 87 | 27 | 5,133 |
| 2012 | 33 | 85 | 85 | 5,203 |
| 2013 | 31 | 128 | 31 | 6,135 |
| 2014 | 33 | 98 | 13 | 6,722 |
| 2015 | 27 | 87 | 11 | 6,881 |
| 2016 | 18 | 88 | 17 | 7,586 |
| 2017 | 25 | 118 | 61 | 12,263 |
| 2018 | 25 | 90 | 14 | 14,071 |
| 2019 | 28 | 133 | 5 | 14,987 |
| 2020 | 22 | 59 | 2 | 12,592 |
| 2021 | 24 | 61 | 8 | 9,408 |
| 2022 | 17 | 56 | 12 | 8,364 |
| 2023 | 20 | 57 | 67 | 8,947 |
| 2024 | 19 | 89 | 7 | 10,828 |
| 2025 | 20 | 55 | 2 | 9,306 |
| 2026 | 12 | 63 | 4 | — |
What is it indicated for?
Total knee replacement is indicated for patients suffering from severe knee pain and disability. Specific indications include femoral, tibial and patellar replacement in a wide size range of patients who require implantation due to degenerative bone disease such as rheumatoid arthwitis or osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle, pseudo-gout or complications from a falled prosthesis.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K961021 · printed Nov 4, 2026
Cite this page
510(k) Report. “K961021: Kirschner Knee Modified.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K961021
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026